HSP90-IN-11
HSP90-IN-11 (Compound 12c) is a potent inhibitor of HSP90. HSP90-IN-11 displays potent HSP90α inhibition comparable to AUY-922 (Luminespib) . HSP90-IN-11 shows significant antiproliferative activity in CRC and NSCLC cells in a double digit nM range. HSP90-IN-11 leads to rapid degradation of client proteins EGFR and Akt in NSCLC cells. HSP90-IN-11 induces significant accumulation of a sub-G1 phase population[1].
Product Specifications
CAS Number
2986564-20-7
UNSPSC
12352005
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsp90-in-11.html
Solubility
10 mM in DMSO
Smiles
CCN(C1=CC=C(C=C1)CN2C(C(F)=CN(C2=O)C3CCCO3)=O)C(C4=CC(C(C)C)=C(C=C4O)O)=O
Molecular Formula
C27H30FN3O6
Molecular Weight
511.54
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Melanoma-associated antigen D2 (MAGED2) Human ELISA Kit
MyoD (MYOD1, Myogenic Differentiation 1, bHLHc1, MYF3, Myf-3, Myoblast determination protein 1, MYOD, Myogenic factor 3, PUM) (BSA & Azide Free) (MaxLight 550) discontinued
